Research has reported that elevated levels of FBP1 are linked to a better prognosis in various tumor diseases including renal cancer, gastric cancer, and lung cancer, suggesting that FBP1 acts an essential part in cancer glucose metabolism. This evidence concerns the gene FBP1 and lung carcinoma.